Envoy Medical (NASDAQ:COCH) Upgraded to Sell at Wall Street Zen

Wall Street Zen upgraded shares of Envoy Medical (NASDAQ:COCH) to a sell rating in a research note published on Saturday morning.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Envoy Medical in a report on Thursday, October 30th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $9.50.

Envoy Medical Stock Performance

Shares of NASDAQ COCH traded down $0.02 during trading on Friday, reaching $0.70. The company had a trading volume of 297,116 shares, compared to its average volume of 657,308. Envoy Medical has a 52 week low of $0.70 and a 52 week high of $2.32. The business’s 50 day moving average price is $0.98 and its 200-day moving average price is $1.31. The stock has a market cap of $18.03 million, a PE ratio of -0.49 and a beta of 2.09.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Envoy Medical stock. NorthRock Partners LLC bought a new stake in Envoy Medical, Inc. (NASDAQ:COCH) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,290,049 shares of the company’s stock, valued at approximately $14,612,000. NorthRock Partners LLC owned approximately 48.25% of Envoy Medical as of its most recent filing with the Securities and Exchange Commission. 8.59% of the stock is currently owned by institutional investors and hedge funds.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.